Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)
CUSIP: 747324101
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 62,130,557
- Total 13F shares
- 19,443,728
- Share change
- -590,593
- Total reported value
- $38,301,000
- Price per share
- $1.97
- Number of holders
- 35
- Value change
- -$1,468,358
- Number of buys
- 16
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 747324101?
CUSIP 747324101 identifies PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 747324101:
Top shareholders of PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Laurion Capital Management LP |
13F
|
Company |
5.1%
|
3,170,803
|
$7,547,000 | — | 30 Jun 2022 | |
| BVF INC/IL |
13F
|
Company |
4.7%
|
2,938,851
|
$6,994,000 | — | 30 Jun 2022 | |
| BARCLAYS PLC |
3/4/5
13F
|
10%+ Owner · Company |
1.5%
from 13F
|
3,477,975
|
$4,869,165 | — | 26 Apr 2022 | |
| Bayer World Investments B.V. |
3/4/5
|
Former 10% Owner |
—
class O/S missing
|
2,742,338
|
$3,839,273 | — | 13 Oct 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
2.5%
|
1,528,812
|
$3,639,000 | — | 30 Jun 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.4%
|
1,520,936
|
$3,620,000 | — | 30 Jun 2022 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.2%
|
1,379,080
|
$3,282,000 | — | 30 Jun 2022 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
1.6%
|
965,459
|
$2,298,000 | — | 30 Jun 2022 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.5%
|
953,393
|
$2,269,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.4%
|
849,080
|
$2,021,000 | — | 30 Jun 2022 | |
| Newtyn Management, LLC |
13F
|
Company |
1.3%
|
800,000
|
$1,904,000 | — | 30 Jun 2022 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
1.2%
|
764,406
|
$1,819,000 | — | 30 Jun 2022 | |
| Tekla Capital Management LLC |
13F
|
Company |
1.1%
|
708,303
|
$1,686,000 | — | 30 Jun 2022 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
1.1%
|
682,220
|
$1,624,000 | — | 30 Jun 2022 | |
| Cormorant Asset Management, LP |
13F
3/4/5
|
Company · Former 10% Owner |
1.1%
|
668,854
|
$1,592,000 | — | 30 Jun 2022 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
1%
|
645,149
|
$1,535,000 | — | 30 Jun 2022 | |
| CITIGROUP INC |
13F
|
Company |
0.5%
|
312,411
|
$744,000 | — | 30 Jun 2022 | |
| Logos Global Management LP |
13F
|
Company |
0.35%
|
220,434
|
$525,000 | — | 30 Jun 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.33%
|
205,304
|
$489,000 | — | 30 Jun 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.23%
|
142,815
|
$340,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.22%
|
136,769
|
$325,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
109,847
|
$261,000 | — | 30 Jun 2022 | |
| Ronald Herbst |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
118,674
mixed-class rows
|
$234,796 | — | 07 Oct 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.12%
|
75,371
|
$179,000 | — | 30 Jun 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
70,295
|
$167,000 | — | 30 Jun 2022 | |
| Ritu Shah |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
31,344
|
$120,048 | — | 07 Oct 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.07%
|
42,296
|
$101,000 | — | 30 Jun 2022 | |
| Ergoteles LLC |
13F
|
Company |
0.06%
|
36,415
|
$87,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.05%
|
30,989
|
$74,000 | — | 30 Jun 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.04%
|
25,000
|
$60,000 | — | 30 Jun 2022 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.04%
|
23,843
|
$57,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
17,742
|
$42,000 | — | 30 Jun 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
15,703
|
$37,000 | — | 30 Jun 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
14,466
|
$34,000 | — | 30 Jun 2022 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.02%
|
13,624
|
$32,000 | — | 30 Jun 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
12,882
|
$31,000 | — | 30 Jun 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
3,060
|
$7,000 | — | 30 Jun 2022 | |
| FMR LLC |
13F
|
Company |
0%
|
858
|
$2,000 | — | 30 Jun 2022 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
833
|
$2,000 | — | 30 Jun 2022 | |
| UBS Group AG |
13F
|
Company |
0%
|
367
|
$1,000 | — | 30 Jun 2022 |
Institutional Holders of Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) as of Q3 2022
As of 30 Sep 2022,
Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,443,728 shares.
The largest 10 holders included
Laurion Capital Management LP, BVF INC/IL, CITADEL ADVISORS LLC, PERCEPTIVE ADVISORS LLC, TANG CAPITAL MANAGEMENT LLC, BARCLAYS PLC, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, Newtyn Management, LLC, and RA CAPITAL MANAGEMENT, L.P..
This page lists
35
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
37
Q3 2022 holders
35
Holder diff
-2
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.